CBC Solutions - Q3 2020

Q3 FY2020

U.S. Army Combat Capabilities Development Command (CCDC) Chemical Biological Center | Newsletter

CCDC Chemical Biological Center

News from the Field


A team of chemical demilitarization experts at from the CCDC Chemical Biological Center’s Chemical Biological Application and Risk Reduction business unit completed an investigation and assessment at a former U.S. chemical depot in New South Wales, Australia. A team of 14 Center employees mobilized, conducted the operation and demobilized in approximately 45 days. The operation began in late February, and the team implemented rigorous COVID-19 safety measures in order to complete the mission and return home safely.

United Kingdom

CCDC Chemical Biological Center researchers collaborated with colleagues at the University of Hertfordshire Research Center for Topical Drug Delivery and Toxicology in Ludgershall, Andover, United Kingdom in late February as a part of a DTRA-funded effort to develop a better understanding of the factors which impact successful mass casualty chemical warfare agent decontamination.


Center researchers participated in a preliminary design review for immediate decontamination in Cambridge, Massachusetts in late February. The review was for a sprayable decontamination slurry that was developed at the Chemical Biological Center but is now being further optimized by an industrial partner under a rapid innovation fund project. This partnership will allow the slurry technology to be transitioned to the warfighter ahead of the original schedule.

South Carolina

A Chemical Biological Center researcher supported safe-to-fly acceptance testing of the Transport Isolation System and two upgraded variants for the U.S. Air Force’s Air Mobility Command for COVID-19 pandemic transport of patients. The testing took place at Joint Base Charleston, South Carolina in March and April.